Information For Authors
- Manuscript Submission Guidelines
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Instructions to Authors
Healthcare Transformation: AI, Automation and Robotics focuses on the most critical technology innovations in artificial intelligence, automation, and robotics, moving the field beyond research to enable the most effective use in the worldwide ecosystem of medicine. These technologies have an important role in the most effective delivery of healthcare in both on-site and remote situations. The Journal presents forward-thinking directives from academic leaders, industry and healthcare executives, and policymakers.
Healthcare Transformation invites all authors to submit any new manuscripts that are to be considered for publication to: http://mc.manuscriptcentral.com/heat All submissions must be submitted through this portal. Questions regarding the appropriateness of your submission may be directed to the Managing Editor, Jamie Devereaux at firstname.lastname@example.org.
Authors must include the article’s title, corresponding author’s name, address, institutional affiliation(s), a telephone and email address. The cover letter should indicate that the work has not previously been published, is not under consideration for publication elsewhere, that all authors have read and agree with the contents of the submission, and that all authors have contributed substantially to the work.
Manuscripts submitted to this Journal must not be under simultaneous consideration elsewhere.
Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc., unless other arrangements are made prior to publication, including CC-BY licensing. By submitting a manuscript to the Journal, the author(s) agree(s) to these conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal. Upon acceptance of any manuscript, all authors will receive a follow-up email with instructions on how to complete our online Copyright Agreement form. It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications. FAILURE BY ALL AUTHORS TO SUBMIT THIS FORM WILL RESULT IN A DELAY OF PUBLICATION. The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright. Alternatively, the copyright form may be completed by logging in to the system using an author’s credentials. Enter your Author Center and complete the forms located under “Manuscripts I Have Coauthored,” or “Manuscripts with Decisions” if you are listed as the corresponding author on the paper. For authors who are US government employees or are prevented from being copyright holders for similar reasons, Liebert Open Access can accommodate non-standard copyright. Please contact email@example.com.
PREPARATION OF MANUSCRIPTS
Original manuscripts submitted for peer review may not exceed 3,000 words, not including abstracts, acknowledgments, disclosures, or references. Submissions of manuscripts must be double-spaced with margins of 1 inch on each side, and ample space on top and bottom.
PLEASE FOLLOW THIS SEQUENCE OF SECTIONS
• Number each page of text consecutively. Number all figures and tables.
• Title page must contain: 1.) the complete title of the article; 2.) the full names (including first names), full mailing addresses, full contact information (telephone, fax, and e-mail address), and affiliations of each author; 3.) a brief running title; 4.) the corresponding author’s complete contact information including full mailing and e-mail addresses.
• Abstract: 250 words or less, without the use of subheadings. References are not permitted in the abstract.
• Introduction: Summarize the background of the technology and its significance and novelty. Results should NOT be included in the introduction.
• Materials and Methods: Specific products and materials should be specified, marked with ™ or ® if they are trademarked or registered. These marks need only be cited at a product’s first mention in the abstract, and then once again in text. All acronyms and their definitions should be spelled out at the first mention; use the acronym thereafter. When using specific brand names, please include the manufacturer’s name and location (including city and state) in parentheses.
• Discussion: The results and discussion sections of articles may be combined for more effective presentation.
• Author Disclosure Statement(s). Immediately following the Acknowledgments section, there should be a header entitled, Author Disclosure Statement. The corresponding author should prepare this statement and include the appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. If no conflicts exist, the authors must state “No competing financial interests exist.” Articles submitted without an “Author Disclosure Statement” will be un-submitted so that a statement may be added. Conflicts include:
1. Competing Interests. A competing interest exists when an individual (or the individual’s institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
2. Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
3. Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
4. Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
5. Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.
All references must be cited in the text using a superscript Arabic number. Arrange the reference list in numeric order as cited in the text. Abbreviate journal names according to Medline. References should be presented in the following style:
Journal citation: Li ST, Pateriti DA, Co JP, West DC. Successful self-directed lifelong learning in medicine: a conceptual model derived from qualitative analysis of a national survey of pediatric residents. Academic Medicine. July 2010; 85:1229-1236.
Book citation: Knowles M. Self-Directed Learning -- A Guide for Learners and Teachers. Association Press, New York: 1975.
Websites: Author [if known]. Name of web page. Web address. (Last accessed on [date]).
When dates from an unpublished source are given, supply the researcher’s name. If the work is in press, give the publication name in which it is to be published.
TABLES AND ILLUSTRATIONS
Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Provide titles for all tables. Define all acronyms in table footnotes. All other types of table footnotes should be designated using superscript letters, not symbols. Include all tables, sequentially, at the end of your manuscript, after the reference section.
All figures must be numbered and cited sequentially within text. Each file name should include the corresponding author’s last name followed by the figure number (Ex: SmithFig1). Include only English alphanumeric characters in file names. Do not use any special characters.
A legend should be supplied for each figure, and all legends numbered consecutively and uploaded as a separate file under the file designation, “Figure Legends.” Any symbols used a figure should be defined either in the figure legend, or as part of a key within the figure. If possible, please use Arial font for figure text. Images should not show the name of any manufacturer, or reveal patient names/identity.
Please follow these instructions carefully when preparing figure files for uploading:
- Do not include any figures as part of your text file.
- Do not prepare any figures in Word.
- Save figures as either TIFF or EPS files. Do not submit JPEG files. (JPEG files are for screen representation-quality only and will print poorly during the printing process.) To ensure proper print quality, please submit only TIFF or EPS files.
- Line illustrations must be submitted at 900 DPI.
- Halftones and color photos should be submitted at a minimum of 300 DPI. (NB: 600 DPI images are more desirable for reproduction.)
- PowerPoint files are not permitted.
Requirements for Using Material from Previously Published Work(s)
• The authors must obtain written permission from the copyright holder of the journal or book concerned for the reproduction of any figures, tables, text, etc. from copyrighted materials.
• The publication from which the figure or table is taken must be listed as a reference in the reference list.
• An appropriate credit line should be included in the figure legend or table footnote, indicating reuse or adaptation.
STUDY DESIGN AND ETHICS
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The Journal does not provide a generic patient release form.
Any identifying information should not be published in descriptions or photographs unless the information is essential for scientific purposes and the patient (or parent/guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be submitted. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.]] Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, the manuscript should contain assurances/statements that such changes do not distort scientific meaning.
In keeping with patients' rights of privacy, the Journal does not require the submission of patient consent forms, but instead requires the author(s) to retain and archive all patient consent
documentation. Upon submission of a manuscript for review, the authors must make a statement in a cover letter to the Editor/Journal which attests they have received and archived written patient consent.
ETHICS OF EXPERIMENTATION
All articles involving the use of human fetuses, fetal tissue, embryos, and embryonic cells must adhere to the US Public Law 103–41, effective December 13, 2001. (http://ethics.od.nih.gov/.)
Ethical Treatment of Animals
All peer-reviewed submissions containing animal experiments must comply with local and national regulatory principles, and contain a statement in the Materials and Methods section stating whether their national and institutional guidelines for the care and use of laboratory animals were followed.
PERMISSIONS AND REPRINTS
Please contact firstname.lastname@example.org for permission to reuse published material in another publication and/or media.
ARCHIVING AND PRESERVATION
Mary Ann Liebert, Inc., deposits and archives all publications in Portico for long-term digital preservation. Additionally, the final published version (version of record) of all articles in the Journal will be deposited upon publication, without embargo, to PubMed Central at the U.S. National Library of Medicine (Please note that PubMed Central, not the Publisher, has sole control over when the paper is made live on PMC.) Healthcare Transformation is fully NIH-, HHMI-, and Wellcome Trust-compliant.
Healthcare Transformation is owned and published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801-5215. Phone: (914) 740-2100; Fax: (914) 740-2101; E-mail: email@example.com; www.liebertpub.com/heat
Healthcare Transformation is a journal of broad interest that has been launched to overcome unnecessary barriers to the immediate availability and use of research.
Benefits of publishing in Healthcare Transformation:
- High visibility, immediate and unrestricted online access to published articles
- Rigorous peer review
- Easy compliance with open access mandates
- Authors retain copyright
- Highly indexed – citation tracking and inclusion in bibliographic databases
- Targeted email marketing
Copyright and Licensing
Healthcare Transformation publishes articles under the liberal CC-BY license. This means that articles can be freely redistributed and reused by the author and others as long as the article is properly cited. Published articles in Healthcare Transformation can be deposited immediately into an online repository or social network without an embargo. Healthcare Transformation articles can be emailed to colleagues, printed, archived in a collection, included in course-packs, and distributed without restrictions. Please read the full Creative Commons license for further information.
The final published version (version of record) of all articles published in Healthcare Transformation are immediately deposited into PubMed Central (PMC) on behalf of the authors. Authors need not take any action. This service is provided free of charge.
*Please note that PubMed Central, not the Publisher, has sole control over when the paper is made live on PMC.
Publishing in Open Access Journals
There are no archiving restrictions for open access articles published under creative commons licenses. Author manuscripts and the final published version of any article published in Healthcare Transformation can be archived in a repository, preprint server, or shared on a research network without an embargo.